Statute · California Health and Safety Code

Cal. Health & Safety Code § 11839.2 — Narcotic Treatment Programs

Cal. Health & Safety Code § 11839.2

Type
Statute
Source
California Health and Safety Code
Jurisdiction
California
Date
2026-06-29
Current through
Nov 2, 2026 (California Legislative Counsel)

The following medications are authorized for use in narcotic replacement therapy and medication-assisted treatment by licensed narcotic treatment programs:

Citator

Cal. Health & Safety Code § 11839.2 — Narcotic Treatment Programs is in force in the current edition of the Code, and nothing recorded condemns it.

The following medications are authorized for use in narcotic replacement therapy and medication-assisted treatment by licensed narcotic treatment programs:

(a) Methadone.

(b) Buprenorphine products or combination of products approved by the federal Food and Drug Administration for treatment of opioid dependence.

(c) Any other medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.

(d) Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section by means of plan or provider bulletins, or similar instructions. The department shall adopt regulations by no later than January 1, 2021.